Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Characterization of Treatment Resistance and Viral Kinetics in the Setting of Single-Active Versus Dual-Active Monoclonal Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae192Source: DataRank Database

Characterization of Treatment Resistance and Viral Kinetics in the Setting of Single-Active Versus Dual-Active Monoclonal Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 is a research paper published in The Journal of Infectious Diseases (2024). On theSindex it has a DataRank of 0. It has been cited 7 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Download PDF

Cite:

Linked data & code

nct pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 2.11)OA: greenTopics (47)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (22)

Rinki Deo,Teresa H. Evering,Kara W Chew ORCID,Mark J Giganti ORCID,Carlee Moser ORCID

Live enrichment

PubMed:38716969 PMC:PMC11326811 OpenAlex:https://openalex.org/W4396748735

National Institutes of Health

Grant: UM1AI068634

National Institutes of Health

Grant: UM1AI068636

National Institutes of Health

Grant: UM1AI106701

NIAID NIH HHS

Grant: UM1 AI069423

NIAID NIH HHS

Grant: UM1 AI069424

NIAID NIH HHS

Grant: UM1 AI069481

NIAID NIH HHS

Grant: UM1 AI069419

National Institute of Allergy and Infectious Diseases

FWCI

2.11

Citation Percentile

0.9%

Citation Trend

2025

2026

greenLicense: https://academic.oup.com/pages/standard-publication-reuse-rights

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11326811/pdf/jiae192.pdf

publisherhttps://academic.oup.com/jid/advance-article-pdf/doi/10.1093/infdis/jiae192/57727412/jiae192.pdf

publisherhttps://academic.oup.com/jid/article-pdf/230/2/394/58809191/jiae192.pdf

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11326811

Fields of Study

SARS-CoV-2 and COVID-19 ResearchMonoclonal and Polyclonal Antibodies Researchvaccines and immunoinformatics approachesHumansSARS-CoV-2FemaleMaleMiddle AgedViral LoadAntibodies, Monoclonal, HumanizedCOVID-19 Drug TreatmentDrug Resistance, ViralAntiviral AgentsCOVID-19Antibodies, MonoclonalAgedAdultDrug Therapy, CombinationSARS-CoV-2 variants

MeSH Terms

COVID-19SARS-CoV-2COVID-19 Drug TreatmentAdultAgedAntibodies, MonoclonalAntiviral AgentsDrug Therapy, CombinationFemaleHumansMaleMiddle AgedViral LoadDrug Resistance, ViralAntibodies, Monoclonal, Humanized

Keywords

Monoclonal antibodySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyAntibodyCoronavirus disease 2019 (COVID-19)Medicine2019-20 coronavirus outbreakImmunologyInternal medicineVariantsViral KineticsMab ResistanceSars-cov-2

Sustainable Development Goals

SDG 0: Good health and well-being

Characterization of Treatment Resistance and Viral Kinetics in the Setting of Single-Active Versus Dual-Active Monoclonal Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2

FAIR Checklist

Authors (22)

Funding (9 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)